1 Del. Admin. Code § 102-7.0

Current through Register Vol. 28, No. 7, January 1, 2025
Section 102-7.0 - Re-Disclosure Requirements
7.1 DHIN may issue public reports containing or based upon de-identified data without Committee review and approval.
7.2 Any other re-disclosure of Available Clinical Data shall require Committee review and approval.
7.3 All Available Clinical Data that is shared publicly or re-disclosed to anyone other than an Approved User shall adhere to federal Centers for Medicare & Medicaid Services ("CMS") cell size suppression requirements for CMS Research Identifiable Files.

1 Del. Admin. Code § 102-7.0

25 DE Reg. 624 (12/1/2021) (final)